Legacy Wealth Planning, LLC Charles River Laboratories International, Inc. Transaction History
Legacy Wealth Planning, LLC
- $60.4 Million
- Q3 2022
A detailed history of Legacy Wealth Planning, LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Legacy Wealth Planning, LLC holds 5,582 shares of CRL stock, worth $840,202. This represents 1.82% of its overall portfolio holdings.
Number of Shares
5,582
Previous 5,582
-0.0%
Holding current value
$840,202
Previous $1.19 Million
7.96%
% of portfolio
1.82%
Previous 1.71%
Shares
6 transactions
Others Institutions Holding CRL
# of Institutions
710Shares Held
50MCall Options Held
122KPut Options Held
239K-
Vanguard Group Inc Valley Forge, PA6.16MShares$927 Million0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$766 Million0.02% of portfolio
-
State Street Corp Boston, MA2.18MShares$328 Million0.02% of portfolio
-
Allspring Global Investments Holdings, LLC1.81MShares$272 Million0.56% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.81MShares$272 Million0.79% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $7.66B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...